TCA
OPK icon

Transcend Capital Advisors’s Opko Health OPK Stock Holding History

Transcend Capital Advisors’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.8K Sell
51,850
-55
-0.1% -$70 0.01% 806
2026
Q1 		$59.2K Sell
51,905
-836
-2% -$1.03K ﹤0.01% 711
2025
Q4 		$66.5K Buy
52,741
+176
+0.3% +$245 0.01% 679
2025
Q3 		$81.5K Buy
52,565
+1,714
+3% +$2.35K 0.01% 686
2025
Q2 		$67.1K Buy
50,851
+1
+0% +$1 0.01% 610
2025
Q1 		$84.4K Hold
50,850
– – 0.01% 595
2024
Q4 		$74.8K Hold
50,850
– – 0.01% 564
2024
Q3 		$75.8K Hold
50,850
– – 0.01% 609
2024
Q2 		$63.6K Hold
50,850
– – ﹤0.01% 591
2024
Q1 		$61K Hold
50,850
– – ﹤0.01% 529
2023
Q4 		$76.8K Hold
50,850
– – 0.01% 499
2023
Q3 		$81.4K Hold
50,850
– – 0.01% 478
2023
Q2 		$110K Hold
50,850
– – 0.01% 472
2023
Q1 		$74.2K Hold
50,850
– – 0.01% 471
2022
Q4 		$63.6K Buy
50,850
+20,000
+65% +$31.5K 0.01% 481
2022
Q3 		$58K Hold
30,850
– – 0.01% 475
2022
Q2 		$78K Sell
30,850
-2,000
-6% -$5.83K 0.01% 485
2022
Q1 		$113K Buy
32,850
+773
+2% +$2.73K 0.01% 498
2021
Q4 		$154K Buy
32,077
+77
+0.2% +$312 0.01% 472
2021
Q3 		$115K Buy
+32,000
New +$119K 0.01% 474
2021
Q2 		– Sell
-42,000
Closed -$180K – 394
2021
Q1 		$180K Hold
42,000
– – 0.02% 391
2020
Q4 		$166K Hold
42,000
– – 0.02% 359
2020
Q3 		$155K Buy
+42,000
New +$177K 0.03% 247
2020
Q2 		– Sell
-30,000
Closed -$40K – 174
2020
Q1 		$40K Buy
+30,000
New +$47K 0.01% 206

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Transcend Capital Advisors's OPK Position: Q2 2026 in Review

Transcend Capital Advisors reduced its Opko Health (OPK) stake by 0.11% in Q2 2026, selling an estimated $70 and leaving 51,850 shares worth $77.8K. The position accounts for 0.01% of the portfolio, ranked #806.

Transcend Capital Advisors first reported a position in OPK in Q1 2020 and has held it in 24 quarters since. The position peaked at $180K in Q1 2021. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Transcend Capital Advisors held 51,850 shares of Opko Health worth $77.8K as of Q2 2026.
  • Transcend Capital Advisors sold 55 Opko Health shares in Q2 2026, an estimated $70.
  • Opko Health made up 0.01% of Transcend Capital Advisors's portfolio in Q2 2026, its #806 holding.
  • Transcend Capital Advisors first reported a position in Opko Health in Q1 2020 and has held it in 24 quarters since.
  • Transcend Capital Advisors's Opko Health position peaked at $180K in Q1 2021.
  • 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.